Skip to main content
. Author manuscript; available in PMC: 2021 Jun 8.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2020 Jun 8;13(6):e006311. doi: 10.1161/CIRCOUTCOMES.119.006311

Figure 3. Prevalence and adjusted prevalence ratios (aPR) for adverse conditions in pregnancies of privately-insured women aged 15–44 with and without congenital heart defects (CHD) 2007–2014.

Figure 3.

aPR: Prevalence ratio for ≥1 complication vs. none adjusted for age, region of residence and year at delivery; CI: Confidence interval; *Pregnancies lasting more than 20 gestational weeks. †Obstetric conditions include gestational diabetes; gestational hypertension, eclampsia or preeclampsia; hemorrhage; hysterectomy; infections including chorioamnionitis, endocarditis, endometritis, endomyometritis, metritis, pyelonephritis, and sepsis; maternal death; obstetric shock; placental abruption; placenta previa; premature rupture of membranes; preterm labor or preterm birth; and transfusion. ‡Cardiac conditions include atrial fibrillation, atrial flutter or supraventricular tachycardia; cardiomyopathy; conduction disorders; coronary dissection; heart failure; incident ventricular tachycardia, ventricular fibrillation, or sudden cardiac arrest; and myocardial infarction or ischemia. §Other conditions include acute renal failure; acute respiratory distress syndrome; anemia; deep vein thrombosis; disseminated intravascular coagulation; mechanical ventilation; pulmonary disease; pulmonary edema; pulmonary embolism; pulmonary hypertension; seizure disorders; stroke or cerebrovascular disorders; and thrombocytopenia.